Sign in
4/A

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-22-000019

Chief Executive Officer bought 38,500 shares at an average $2.04 ($78,397)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-12 Purchase : show line 1 in the form +21,900 $1.99 $43,537 237,812 I
2022-10-13 Purchase : show line 2 in the form +16,600 $2.10 $34,860 254,412 I
Open-market purchases · 38,500 sh · avg $2.04 · $78,397
Loading xslF345X03/primary_doc.xml…